Search clinical trials for: QLF31907

Total 9 results

Qilu Pharmaceutical Co., Ltd.

Recruiting

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

Melanoma | Urothelial Carcinoma

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Lymphoma, Non-Hodgkin | Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS31905 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients

Advanced Solid Tumors

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLF3108 in Participants With Advanced Solid Tumor

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies

Advanced Malignant Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Advanced Malignant Neoplasm
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Solid Tumor

China

3

Subscribe